Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03662698 · ClinicalTrials.gov registry record · NA

Effect of Guided Imagery for Radiotherapy-Related Distress in Patients With Head and Neck Cancer

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
57
Enrollment target

NCT03662698: Completed NA study, sponsored by University of Colorado, Denver.

NCT03662698 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 57 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03662698, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
57 participants
Enrollment target

Study Summary

The goal of this interdisciplinary pilot study is to evaluate the feasibility, acceptability and preliminary efficacy of a guided imagery intervention to reduce radiotherapy-related symptoms of anxiety and depression in patients with head and neck cancers relative to treatment as usual.

Primary Outcome

Feasibility of intervention use will be assessed through rates of study completion.

Interventions

  • OTHER Treatment as Usual
  • BEHAVIORAL Guided Imagery

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2018-10-12
Est. Completion 2021-01-08
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT03662698 record still lists

NCT03662698 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual is the first listed.

NCT03662698 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03662698 about?

NCT03662698 is a clinical study titled "Effect of Guided Imagery for Radiotherapy-Related Distress in Patients With Head and Neck Cancer". The goal of this interdisciplinary pilot study is to evaluate the feasibility, acceptability and preliminary efficacy of a guided imagery intervention to reduce radiotherapy-related symptoms of anxiety and depression in patients with head and neck cancers relative to treatment as usual.

What is the current status of trial NCT03662698?

This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2018-10-12. Estimated completion is 2021-01-08.

What interventions are being tested in trial NCT03662698?

The interventions under investigation include: Treatment as Usual (OTHER), Guided Imagery (BEHAVIORAL).

Who is sponsoring clinical trial NCT03662698?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03662698's enrollment target sits among peer trials

57 1261st of 2000 higher than 739 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03521830 · 57 participants · Phase 2

    Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

  • NCT03587701 · 57 participants · Phase 2

    Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease

  • NCT04104126 · 57 participants · NA

    Blood Flow Restriction Therapy in Achilles Injury

  • NCT04703842 · 57 participants · Phase 1

    Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03662698, the US trial registry maintained by the National Library of Medicine. NCT03662698 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.